Skip to main content

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Centerra Gold Inc. (CG-T) said it has agreed with the government of the Kyrgyz Republic to extend the date that all conditions need to be met in a recent agreement to Nov. 2 from Aug. 24.

The company said it "continues to work with the government of the Kyrgyz Republic to ensure the satisfaction of the remaining conditions precedent to completion of the strategic agreement, including the termination of certain legal proceedings and receipt of finalized land use certificates."

Story continues below advertisement

First Longstop Date under the Strategic Agreement for (“Strategic Agreement”) previously entered into with the Government of the Kyrgyz Republic on September 11, 2017. The First Longstop Date is the

**

Madalena Energy Inc. (MVN-X) reported second-quarter oil and gas revenue of $9.8-million up from $9.4-million a year earlier. Its net loss was $3.5-million or a penny per share versus a loss of $5.5-million or a penny per share a year earlier.

**

GreenSpace Brands Inc. (JTR-X) reported record gross revenue of $21-million in its first quarter, a 48-per-cent increase over the prior year period and slightly above expectations of $20.5-million. Adjusted EBITDA was $388,000 versus $444,000 a year ago.

**

Huu-ay-aht First Nations and Western Forest Products Inc. (WEF-T) say they're working together to explore "potential alternative ownership structures" in Huu-ay-aht’s traditional territories as part of a Reconciliation Protocol Agreement. "This collaborative effort may also involve other First Nations with traditional territories in the Alberni Valley over the next several years. Western and Huu-ay-aht both strongly believe that working together will benefit the community, region and forestry sector," the company stated in a release.

Story continues below advertisement

**

Village Farms International, Inc. (VFF-T) and Emerald Health Therapeutics Inc. (EMH-X) say their Pure Sunfarms joint venture received from Health Canada its third amendment to the cultivation license for its Delta 3 greenhouse in Delta, BC.

The amendment permits Pure Sunfarms to expand its cannabis production area by 195,000 square feet to approximately 420,000 square feet of the 1.1-million square foot Delta 3 production facility.

"We are thrilled with the rapid pace at which the Pure Sunfarms team continues to complete conversion of additional production area, as well as the rapid pace at which it has been able to secure amendments to its cultivation license to steadily expand production," said Michael DeGiglio, CEO of Village Farms.

**

CannaRoyalty Corp. (CRZ-C) reported second-quarter revenues of $3.5-million as compared to $960,157 a year earlier. Net income of $9.3-million or 17 cents per share compared to a net loss of $2-million or 5 cents a year ago.

Story continues below advertisement

**

Maverix Metals Inc. (MMX-X) says it has acquired a 1.5-per-cent net smelter returns royalty on the McCoy-Cove project in Nevada.

"The McCoy-Cove royalty was originally intended to be included in the royalty portfolio that Maverix recently acquired from Newmont Mining Corp, but was subject to a right of first refusal (ROFR) in favour of Premier Gold Mines Ltd.," the company stated.

Premier has provided notice to Newmont that it will not be proceeding with the ROFR exercise. "As a result of the ROFR not being exercised, Newmont has transferred the McCoy-Cove Royalty to Maverix," the company stated.

The company also reported second-quarter revenue of $8.5-million up from $4-million for the same quarter last year and slightly ahead of expectations of $8.3-million. Its net loss was $458,000 versus a profit of $204,000 a year ago.

**

Story continues below advertisement

Emblem Corp. (EMC-X) said it has established a working capital advance for Natura Naturals Holdings Inc. to support the completion of phase 1 construction of a licensed greenhouse that is currently undergoing a phased conversion and retrofit.

The advance funding includes a one-year convertible debenture for up to $2-million. The advance is convertible into Natura shares at a price of 80 cents each plus one full share purchase warrant exercisable at $1.05.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter